Direct Oral Anticoagulants (DOACs)

Type: drug

Status: FDA Approved

Developer: Bayer, Bristol Myers Squibb, Pfizer, Boehringer Ingelheim

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026